CLINICAL_TRIALS
trial_result
· 2021-03-24
Clinical Trial Update: A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis [Phase 2]
Summary
Phase 2 trial evaluating three doses of OPS-2071 in patients with bacterial enteritis has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Bacterial Enteritis | Phase 2 | Status: COMPLETED | Results posted: 2021-03-24